General Information of This Antigen (ID: TAR0OXEAL)
Antigen Name
Fibroblast growth factor receptor 2 (FGFR2)
Gene Name
FGFR2
Gene ID
2263
Synonym
BEK; KGFR; KSAM; K-sam;Keratinocyte growth factor receptor;CD332
Sequence
MVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGESLEV
RCLLKDAAVISWTKDGVHLGPNNRTVLIGEYLQIKGATPRDSGLYACTASRTVDSETWYF
MVNVTDAISSGDDEDDTDGAEDFVSENSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCP
AGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSI
NHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSK
YGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVL
PAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVHKLTK
RIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDK
LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM
IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF
KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT
TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH
RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQPLEQYS
PSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT

    Click to Show/Hide
Family
Tyr protein family
Function
Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, trophoblast function, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. Promotes cell proliferation in keratinocytes and immature osteoblasts, but promotes apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and PAK4. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal FGFR2 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1.

    Click to Show/Hide
Uniprot Entry
FGFR2_HUMAN
HGNC ID
HGNC:3689
KEGG ID
hsa:2263
Each Antibody-drug Conjugate and Its Component Related to This Antigen
Full List of The ADC Related to This Antigen
The Numbers of ADCs, Their Three Components, Payload Targets, and Corresponding Diseases for This Antigens
Anti-FGFR2 antibody
ADC Name Payload Target Linker ADC Info
BG-C137 [1]
TOP1 inhibitor
DNA topoisomerase 1 (TOP1)
A cleavable linker
HDM2020
TOP1 inhibitor
DNA topoisomerase 1 (TOP1)
A cleavable linker
3H-10000
Undisclosed
Undisclosed
Undisclosed
Anti-FGFR2 mAb
ADC Name Payload Target Linker ADC Info
ALK201
Exatecan
DNA topoisomerase 1 (TOP1)
A cleavable linker
Anti-FGFR2 mAb 10164
ADC Name Payload Target Linker ADC Info
Anti-FGFR2 mAb-10164 SMCC-DM1 [2]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Anti-FGFR2 mAb-10164 SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
Anti-FGFR2 mAb-10164 CX1-1-DM1 [2]
Mertansine DM1
Microtubule (MT)
2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)
Anti-FGFR2 mAb-10164 SSNPP-DM3 [2]
Maytansinoid DM3
Microtubule (MT)
Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)
Anti-FGFR2 mAb-10164 SPP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
Anti-FGFR2 mAb-10164 Sulfo-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
Sulfo-SPDB
Anti-FGFR2 mAb-10164 SPDP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)
Anti-FGFR2 mAb 10220
ADC Name Payload Target Linker ADC Info
Anti-FGFR2 mAb-10220 SMCC-DM1 [2]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Anti-FGFR2 mAb-10220 SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
Anti-FGFR2 mAb-10220 CX1-1-DM1 [2]
Mertansine DM1
Microtubule (MT)
2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)
Anti-FGFR2 mAb-10220 SSNPP-DM3 [2]
Maytansinoid DM3
Microtubule (MT)
Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)
Anti-FGFR2 mAb-10220 SPP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
Anti-FGFR2 mAb-10220 Sulfo-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
Sulfo-SPDB
Anti-FGFR2 mAb-10220 SPDP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)
Anti-FGFR2 mAb 10846
ADC Name Payload Target Linker ADC Info
Anti-FGFR2 mAb-10846 SMCC-DM1 [2]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Anti-FGFR2 mAb-10846 SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
Anti-FGFR2 mAb-10846 CX1-1-DM1 [2]
Mertansine DM1
Microtubule (MT)
2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)
Anti-FGFR2 mAb-10846 SSNPP-DM3 [2]
Maytansinoid DM3
Microtubule (MT)
Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)
Anti-FGFR2 mAb-10846 SPP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
Anti-FGFR2 mAb-10846 Sulfo-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
Sulfo-SPDB
Anti-FGFR2 mAb-10846 SPDP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)
Anti-FGFR2 mAb 11723
ADC Name Payload Target Linker ADC Info
Anti-FGFR2 mAb-11723 SMCC-DM1 [2]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Anti-FGFR2 mAb-11723 SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
Anti-FGFR2 mAb-11723 CX1-1-DM1 [2]
Mertansine DM1
Microtubule (MT)
2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)
Anti-FGFR2 mAb-11723 SSNPP-DM3 [2]
Maytansinoid DM3
Microtubule (MT)
Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)
Anti-FGFR2 mAb-11723 SPP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
Anti-FGFR2 mAb-11723 Sulfo-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
Sulfo-SPDB
Anti-FGFR2 mAb-11723 SPDP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)
Anti-FGFR2 mAb 11725
ADC Name Payload Target Linker ADC Info
Anti-FGFR2 mAb-11725 SMCC-DM1 [2]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Anti-FGFR2 mAb-11725 SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
Anti-FGFR2 mAb-11725 CX1-1-DM1 [2]
Mertansine DM1
Microtubule (MT)
2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)
Anti-FGFR2 mAb-11725 SSNPP-DM3 [2]
Maytansinoid DM3
Microtubule (MT)
Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)
Anti-FGFR2 mAb-11725 SPP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
Anti-FGFR2 mAb-11725 Sulfo-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
Sulfo-SPDB
Anti-FGFR2 mAb-11725 SPDP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)
Anti-FGFR2 mAb 12433
ADC Name Payload Target Linker ADC Info
Anti-FGFR2 mAb-12433 SMCC-DM1 [2]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Anti-FGFR2 mAb-12433 SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
Anti-FGFR2 mAb-12433 CX1-1-DM1 [2]
Mertansine DM1
Microtubule (MT)
2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)
Anti-FGFR2 mAb-12433 SSNPP-DM3 [2]
Maytansinoid DM3
Microtubule (MT)
Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)
Anti-FGFR2 mAb-12433 SPP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
Anti-FGFR2 mAb-12433 Sulfo-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
Sulfo-SPDB
Anti-FGFR2 mAb-12433 SPDP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)
Anti-FGFR2 mAb 12931
ADC Name Payload Target Linker ADC Info
Anti-FGFR2 mAb-12931 SMCC-DM1 [2]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Anti-FGFR2 mAb-12931 SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
Anti-FGFR2 mAb-12931 CX1-1-DM1 [2]
Mertansine DM1
Microtubule (MT)
2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)
Anti-FGFR2 mAb-12931 SSNPP-DM3 [2]
Maytansinoid DM3
Microtubule (MT)
Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)
Anti-FGFR2 mAb-12931 SPP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
Anti-FGFR2 mAb-12931 Sulfo-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
Sulfo-SPDB
Anti-FGFR2 mAb-12931 SPDP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)
Anti-FGFR2 mAb 12944
ADC Name Payload Target Linker ADC Info
Anti-FGFR2 mAb-12944 SMCC-DM1 [2]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Anti-FGFR2 mAb-12944 SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
Anti-FGFR2 mAb-12944 CX1-1-DM1 [2]
Mertansine DM1
Microtubule (MT)
2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)
Anti-FGFR2 mAb-12944 SSNPP-DM3 [2]
Maytansinoid DM3
Microtubule (MT)
Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)
Anti-FGFR2 mAb-12944 SPP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
Anti-FGFR2 mAb-12944 Sulfo-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
Sulfo-SPDB
Anti-FGFR2 mAb-12944 SPDP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)
Anti-FGFR2 mAb 12947
ADC Name Payload Target Linker ADC Info
Anti-FGFR2 mAb-12947 SMCC-DM1 [2]
Mertansine DM1
Microtubule (MT)
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC)
Anti-FGFR2 mAb-12947 SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB)
Anti-FGFR2 mAb-12947 CX1-1-DM1 [2]
Mertansine DM1
Microtubule (MT)
2,5-Dioxopyrrolidin-1-yl 17-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5,8,11,14-tetraazaheptadecan-1-oate (CX1-1)
Anti-FGFR2 mAb-12947 SSNPP-DM3 [2]
Maytansinoid DM3
Microtubule (MT)
Sulfosuccinimidyl-N-succinimidyl-4-(5-nitro-2-pyridyldithio) pentanoate (SSNPP)
Anti-FGFR2 mAb-12947 SPP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP)
Anti-FGFR2 mAb-12947 Sulfo-SPDB-DM4 [2]
Mertansine DM4
Microtubule (MT)
Sulfo-SPDB
Anti-FGFR2 mAb-12947 SPDP-DM1 [2]
Mertansine DM1
Microtubule (MT)
N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP)
Anti-FGFR2 scFv ECD_FGFR2
ADC Name Payload Target Linker ADC Info
ScFvF7-Fc-vcMMAE [3]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Anti-FGFR2b IgG1 antibody
ADC Name Payload Target Linker ADC Info
SIM 0686
CPT116
DNA topoisomerase 1 (TOP1)
A cleavable linker
Aprutumab
ADC Name Payload Target Linker ADC Info
Aprutumab ixadotin
Auristatin W
Microtubule (MT)
Caproyl acid
Bemarituzumab
ADC Name Payload Target Linker ADC Info
SCR-A002 [4]
Undisclosed
Undisclosed
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
PBX-004 [5]
Undisclosed
Undisclosed
Undisclosed
FGFR2b-1-BL12- LP1 [6]
US12209180B2 P3
Undisclosed
Anti-Her2-AL1- LP1 LINKER
FGFR2b-1-AL1- LP1 [6]
US12209180B2 P3
Undisclosed
Anti-Her2-AL1- LP1 LINKER
FGFR2b-1-AL1- LP35 [6]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP35 LINKER linker
FGFR2b-1-AL1- LP32 [6]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP32 linker
FGFR2b-1-AL1- LP39 [6]
Undisclosed
Undisclosed
Undisclosed
FGFR2b-1-AL1- LP38 [6]
Undisclosed
Undisclosed
Anti-Her2-AL1- LP38 linker
FGFR2b-1-BL12 LP2 [6]
US12209180B2 P3
Undisclosed
Anti-Her2-AL1- LP2 LINKER
References
Ref 1 Preclinical evaluation of BG-C137, a potential first-in-class FGFR2b-targeting ADC, for the treatment of FGFR2b-expressing cancer
Ref 2 Antibody drug conjugates.
Ref 3 Generation of high-affinity, internalizing anti-FGFR2 single-chain variable antibody fragment fused with Fc for targeting gastrointestinal cancers. PLoS One. 2018 Feb 8;13(2):e0192194. doi: 10.1371/journal.pone.0192194. eCollection 2018.
Ref 4 SCR-A002, a novel FGFR2b-targeting ADC for solid tumors
Ref 5 Introduction to basic information on ADC drug PBX-004
Ref 6 Protein-drug conjugates comprising camptothecin analogs and methods of use thereof